Cue Biopharma Announces Pricing of $12.0 Million Public Offering
Oppenheimer & Co. Inc. is acting as sole book-running manager for the offering. Newbridge Securities Corporation is acting as co-manager for the offering.
bovnews12d
Cue Biopharma Inc (CUE) Stock: Surpassing Expectations in the Market?
On Friday, Cue Biopharma Inc (CUE) stock saw a modest uptick, ending the day at $0.68 which represents a slight increase of $0.23 or 51.11% from the prior close of $0.45. The stock opened at $0.46 and ...
Farmers Weekly11d
First impressions: John Deere’s bonkers-big 913hp 9RX 830
John Deere’s new 9RX 830 is the biggest, most powerful and most expensive tractor ever to go into series production. In pure ...
Mendocino Beacon9d
Cue Tips: Don’t miss the easy shot
We have watched this season as League matches continue to surprise us with unpredictable outcomes. When you are playing multiple pool games with an opponent, you may win the first ...